Founded in 2002, 5AM Ventures is a seed and early stage venture capital firm that currently has 97 investments in 50 different companies and $1 billion under management. The Venture Partners take a hands on approach to build next generation live science companies capable of solving healthcare need by creating breakthroughs in medicine and science to diagnose, prevent and treat medical conditions. 5AM even become directly involved in setting company strategy, business development, management recruiting and fund raising, even sometimes taking on short term operating roles. Their teams are made up of professionals with strong scientific, medical, legal, finance and operational expertise. Managing partner, Scott Rocklage, Ph.D., has over 30 years of experience in healthcare management and a scientific background. He has served in many leadership role in companies including Chairman and Chief Operating Office of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, and R&D positions with Salutar and Catalytical. His leadership roles helped three new drug applications gain FDA approval.
Ideamensh.com, who states its purpose as inspiring action through publishing daily interviews and information provided by real entrepreneurs, published an interview with Dr. Rocklage in which he revealed that the name “5AM” was chosen because it is really early in the morning, like early stage company formation. He also shared that for him there is no “typical”day but his days vary among working with portfolio company’s’ management teams, preparing and attending board meetings and studying new areas of life science. Dr. Rocklage stated that scientist, physicians and business executives are entrepreneurs his firm assist to bring their ideas to life by creating medicines to treat unmet needs. His vast experience has given him insight into success and his habit of being well organized with regards to time management, prioritizing and calendaring has made him a productive entrepreneur. He has learned to focus even more on people and team selection from the very beginning of a new company. Taking risk and being true to what your business knows it does well is the strategy that helps him grow his business.
Dr. Rocklage, received his B. S. in chemistry from the University of California, Berkeley and his Ph. D. from MIT. He conducted research in the laboratory of 2005 Nobel Prize winner in chemistry, Richard Schrock. He also is an inventor with 30 U. S. patents and the author of more than 100 peer reviewed publications. Dr Rocklage and the 5AM team take active roles in managing and operating businesses as board members, operation managers and strategist leading to the creation of successful companies that solve medical problems.